Citation | Cadilla, R; Deaton, DN; Do, Y; Elkins, PA; Ennulat, D; Guss, JH; Holt, J; Jeune, MR; King, AG; Klapwijk, JC; Kramer, HF; Kramer, NJ; Laffan, SB; Masuria, PI; McDougal, AV; Mortenson, PN; Musetti, C; Peckham, GE; Pietrak, BL; Poole, C; Price, DJ; Rendina, AR; Sati, G; Saxty, G; Shearer, BG; Shewchuk, LM; Sneddon, HF; Stewart, EL; Stuart, JD; Thomas, DN; Thomson, SA; Ward, P; Wilson, JW; Xu, T; Youngman, MA The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure. Bioorg Med Chem28:0 (2020) [PubMed] |
---|
SMILES | OC[C@@H](N[C@H]1CC[C@@H](CC1)NC(=O)c1cnc2cc(ncc2c1)C1CC1)C(F)(F)F |r,wU:7.10,wD:4.3,2.29,(10.1,2.59,;8.76,3.36,;7.43,2.59,;6.1,3.36,;4.76,2.59,;3.43,3.36,;2.1,2.59,;2.1,1.05,;3.43,.28,;4.76,1.05,;.76,.28,;-.57,1.05,;-.57,2.59,;-1.91,.28,;-1.91,-1.26,;-3.24,-2.03,;-4.57,-1.26,;-5.89,-2.02,;-7.22,-1.26,;-7.22,.27,;-5.91,1.04,;-4.57,.28,;-3.24,1.05,;-8.56,-2.03,;-9.33,-3.36,;-10.1,-2.03,;7.43,1.05,;8.76,.28,;6.1,.28,;7.43,-.49,)| |